These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32890764)

  • 1. Diagnostic accuracy of hepatocyte growth factor, Fas/CD95 and Endostatin for non-invasive assessment of hepatic fibrosis in biopsy-proven hepatitis C virus patients.
    Abdelgawad ME; El-Zakzok H; Salah M; El-Mezayen HA
    Infect Genet Evol; 2020 Nov; 85():104526. PubMed ID: 32890764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link.
    Toson EA; Shiha GE; El-Mezayen HA; Samir W; El-Khininy MM
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):199-207. PubMed ID: 27930387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Toson el-SA; Shiha GE; El-Mezayen HA; El-Sharkawy AM
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):931-9. PubMed ID: 27159125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of extrinsic apoptosis pathway in hepatitis C virus patients: apoptosis fibrosis crosstalk.
    Toson EA; Shiha GE; El-Sharkawy AM; El-Mezayen HA
    Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):990-997. PubMed ID: 31743229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients.
    Attallah AM; El-Far M; Omran MM; Farid K; Albannan MS; El-Dosoky I
    J Clin Lab Anal; 2013 Mar; 27(2):121-9. PubMed ID: 23460258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.
    Attallah AM; El-Far M; Abdel Malak CA; Omran MM; Farid K; Hussien MA; Albannan MS; Attallah AA; Elbendary MS; Elbesh DA; Elmenier NA; Abdallah MO
    Ann Hepatol; 2015; 14(2):225-33. PubMed ID: 25671832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
    El-Mezayen HA; Habib S; Marzok HF; Saad MH
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
    Resino S; Bellón JM; Asensio C; Micheloud D; Miralles P; Vargas A; Catalán P; López JC; Alvarez E; Cosin J; Lorente R; Muñoz-Fernández MA; Berenguer J
    BMC Infect Dis; 2010 Aug; 10():244. PubMed ID: 20723207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.
    Alboraie M; Khairy M; Elsharkawy A; Elsharkawy M; Asem N; Abo El-Seoud AR; Elghamry FG; Esmat G
    Saudi J Gastroenterol; 2014; 20(3):170-4. PubMed ID: 24976280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG; Senousy MA
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients.
    Attallah AM; Abdallah SO; Attallah AA; Omran MM; Farid K; Nasif WA; Shiha GE; Abdel-Aziz AA; Rasafy N; Shaker YM
    Ann Hepatol; 2013; 12(1):44-53. PubMed ID: 23293193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor and chronic hepatitis C.
    Marín-Serrano E; Rodríguez-Ramos C; Díaz-García F; Martín-Herrera L; Fernández-Gutiérrez-Del-Alamo C; Girón-González JA
    Rev Esp Enferm Dig; 2010 Jun; 102(6):365-71. PubMed ID: 20575596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis.
    Attallah AM; Albannan MS; Omran MM; Zayed R; Saif S; Farid A; Hassany M; Yosry A; Omran D
    Br J Biomed Sci; 2019 Jul; 76(3):105-110. PubMed ID: 30924403
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection.
    El-Kamary SS; Mohamed MM; El-Raziky M; Shardell MD; Shaker OG; ElAkel WA; Esmat G
    Liver Int; 2013 Aug; 33(7):982-90. PubMed ID: 23509874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.